During the past decade, Waverly Hematology Oncology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 20 clinical trials were completed, i.e. on average, 74.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waverly Hematology Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Novartis Pharmaceuticals" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waverly Hematology Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "NSABP Foundation Inc" with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Waverly Hematology Oncology" are "Breast Cancer" (7 trials), "Breast Carcinoma" (4 trials), "Multiple Myeloma" (4 trials), "Breast Adenocarcinoma" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Waverly Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Waverly Hematology Oncology" are "Drug" (33 trials), "Other" (21 trials), "Biological" (8 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Quality-of-Life Assessment" (9 trials), "Placebo" (7 trials), "Cyclophosphamide" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Waverly Hematology Oncology" are 33 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Waverly Hematology Oncology". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Waverly Hematology Oncology, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Waverly Hematology Oncology, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".